Our Team

Mr. Snow is a nationally recognized healthcare executive with 40 years of experience leading Fortune 50 companies, health plans, hospitals and several innovative healthcare start-ups. He has been featured in numerous articles and is a frequently sought after public speaker. Mr. Snow was acknowledged as one of America’s Best CEO’s by Institutional Investor in 2008, and in 2010, he was named #27 on the Harvard Business Review list of “Best Performing CEO’s in the World”. Additionally, Mr. Snow was recognized as the regional E&Y Entrepreneur of the Year in 2006 along with being a national finalist, and was also named a regional finalist as the Cedar Gate CEO in 2021.

Mr. Snow is currently the Founder, Chairman and CEO of Cedar Gate Technologies, a provider of technology-powered end-to-end solutions designed to enable customer success in value-based care, encompassing enterprise data management, analytics, population health, bundles and capitation technologies, along with other managed and consulting services.

Prior to Cedar Gate Technologies, Mr. Snow was the Chairman & CEO of Medco Health Solutions, a Fortune 34 company. Mr. Snow took Medco public in 2003 and grew it from $30 billion to $72 billion in revenue over a 9 year period. Before Medco, Mr. Snow held positions including President and COO of Empire Blue Cross Blue Shield, EVP of Oxford Health Plans and President of HMO New Jersey for US Healthcare. Earlier in his career, Mr. Snow founded his first company, Managed Healthcare Systems (later renamed AmeriChoice), which was later sold to United Healthcare.

He is Chairman of the Board for Teladoc, Inc., which is publicly traded on the NYSE. Mr. Snow is also on the Board of Premise Health and he is Chairman of the Board of Visitors for the Fuqua School of Business at Duke University.

Mr. Snow holds a Bachelors Degree from Bates College, and a Masters Degree in Healthcare Administration from the Fuqua School of Business, Duke University. He and his family reside in Darien, Connecticut.

Libby Connolly Alexander is an experienced business leader and philanthropist who serves on the boards of several well-known businesses and organizations.  She served as Chief Executive Officer of Connolly, Inc. from 2012 to 2014, leading the company through its acquisition of iHealth Technologies. She then served as the Vice Chairman of the Board of Directors of the combined organization, Cotiviti, as it went public in May of 2016 at a market valuation of $2.55 billion.  Two years later, Cotiviti was acquired by Veritas Capital-backed healthcare data solutions provider Verscend at a transaction value of $4.89 billion.

Libby established her company’s healthcare practice in 1998 and was responsible for building it into a leader in the payment analytics and integrity space prior to the sale of the company.  Cotiviti’s clients included 20 of the top 25 largest U.S. healthcare insurers, eight of the top 10 U.S. retailers, and the Centers of Medicare and Medicaid (CMS).

Libby is also the author Figuring It Out, a memoir of her experience taking Connolly from a PC-driven data mining and analytics company into the untapped healthcare payment integrity industry, harnessing a growth engine along the way unlike any previously leveraged.

Libby serves on the boards of Cedar Gate Technologies, Tulane University, and the Eaglebrook School, and is a strategic advisor to Save the Sound as well as several other local community organizations.  She holds a BA from Tulane University.

Sean joined GTCR in 2001 and is currently a Managing Director of the firm. He was previously a Consultant with The Boston Consulting Group. Sean holds an MBA from the Wharton School at the University of Pennsylvania as well as AB and BE degrees in engineering sciences from Dartmouth College.

Sean currently is a Director of Albany Molecular Research, Ceba-Tech, Cedar Gate Technologies, Cole-Parmer, Corza Health, Maravai LifeSciences, Regatta, Riverchase Dermatology, Sotera and Transaction Data Systems. He was instrumental in GTCR’s past investments in Cord Blood Registry, Devicor Medical Products, Graceway Pharmaceuticals and Ovation Pharmaceuticals.

Pooja Goel is Managing Director for healthcare services investments at Ascension Ventures. She is responsible for co-leading the portfolio investment strategy and seeks out new opportunities for partnership. Within healthcare services, her focus has been value-based care, senior offerings, and tech-enabled services for chronic condition management. Her operational background and experience lend great ability to create value with emphasis on new market expansion and scale.

Prior to joining AV, Pooja was a Partner at Virgo Investment Group responsible for the healthcare practice. She has spent over two decades in the healthcare industry, grappling firsthand with healthcare megatrends and their consequences. This includes the high cost of care for patients with multiple chronic conditions, the need to address social determinants of health, shift in payment models from volume to value, decentralization of care, and increasing emphasis on the patient/family experience. Pooja worked previously as National General Manager for new business at Landmark Health. Before that she served as Group Vice President for the Southern California market for Healthcare Partners, overseeing several thousands of MA lives, employed/affiliated providers and medical clinics/urgent care centers.

Prior to shifting to value-based care roles, Pooja served as Vice President for International Market Entry/Integration at DaVita and led a team that identified opportunities for new M&A in Europe, Latin America, Asia & the Middle East. She served for the office of the C.O.O at DaVita, responsible for many transformational initiatives while holding several key operational roles in domestic and international kidney care. Pooja began her career in hospital operations at multiple academic medical centers, including Kaiser Permanente as an Administrative Fellow. She holds a bachelor’s degree in microbiology and molecular genetics from the University of California, Los Angeles, and a master’s degree in health administration from the Loma Linda University School of Public Health.

John joined GTCR in 2006 and is a Managing Director in the Healthcare group. Prior to joining GTCR, he worked as an Analyst in the Healthcare investment banking group of Citigroup Global Markets in New York. John holds an MBA with distinction from Harvard Business School and a BS in finance with highest honors from the University of Illinois.

He currently serves as a Director of Cedar Gate Technologies and Transaction Data Systems and works closely with Antylia Scientific, Experity and Water’s Edge/Riverchase Dermatology. He was previously involved in past GTCR investments CCS, Cole-Parmer, GreatCall and XIFIN.

Dr. David Levy is the Chief Executive Officer at EHE Health. He is an accomplished physician executive with a record of achievement in founding, leading, and/or turning around a variety of health care services companies focused on improving human health.

As a primary care physician and epidemiologist, Dr. Levy started his career in private practice in suburban New York City. There he founded Franklin Health Inc., (now owned by Optum), the innovator and leader in advocating for patients with highly complex illnesses. He then went on to PwC, and as a partner ultimately led its global health care business for several years. Dr. Levy serves on the boards of leading device, technology, and services companies in the US, Israel, and Brazil.

Dr. Levy is a renowned strategic thinker who has executed effective strategies for his own enterprises and a diverse set of public and private sector entities. Drawing on a vast network of business relationships, Dr. Levy brings global best-in-practice solutions to the healthcare industry.

Dean joined GTCR in 2001 and is currently a Co-CEO and Managing Director of the firm. Prior to joining GTCR, Dean was CEO and co-founder of Delray Farms, LLC, a specialty food retailer. Prior to that, Dean was with McKinsey & Company. Dean holds an MBA with distinction from the Harvard Business School and a BS with high distinction in finance and economics from the University of Illinois, Chicago.

Dean is head of the Healthcare group at GTCR and has been instrumental in building the firm’s expertise in pharma, life sciences and medical devices. He is currently a Director of Antylia Scientific, Ceba-Tech, Cedar Gate Technologies, Corza Health, Curia, Maravai LifeSciences, Resonetics, Sotera Health and TerSera Therapeutics. Dean was previously a Director of past GTCR investments, including Actient Pharmaceuticals, ATI Physical Therapy, Convergex, Cord Blood Registry, Crealta Pharmaceuticals, Curo Health Services, Dash, Devicor Medical Products, GreatCall, Managed Healthcare Associates, Ovation Pharmaceuticals, Riverchase Dermatology, TDS (formerly Rx30) and XIFIN.

Dean was highly involved with Chicago Public Media for over 10 years, serving as a board member and Chair of the Finance Committee.

Leslie Norwalk is Strategic Counsel to Epstein Becker Green, P.C., EBG Advisors and National Health Advisors. She serves as an advisor to several private equity firms; and in addition to Cedar Gate, currently sits on the boards of directors of Arvinas, Magellan Health, Neurocrine Biosciences, NuVasive, Providence Service Corp., CareCentrix, Abode Healthcare, Linkwell Health. She is also a member of APCO Worldwide’s International Advisory Council.

Ms. Norwalk served the Bush Administration as the Acting Administrator for the Centers for Medicare & Medicaid Services (CMS). She managed the day-to-day operations of Medicare, Medicaid, State Child Health Insurance Programs, Survey and Certification of health care facilities and other federal health care initiatives. For four years prior to that, she was the agency’s Deputy Administrator, responsible for the implementation of the hundreds of changes made under the Medicare Modernization Act, including the Medicare Prescription Drug Benefit.
CMS has the second-largest budget outlay of the Federal Government, directly responsible for $1 out of every $3 spent on healthcare in the United States. The organization insures approximately a third of the population of the United States (more than 100 million beneficiaries) including the elderly, disabled, and some of the lowest income individuals in the country. CMS processes over one billion claims each year and contracts with approximately one million providers.

Prior to serving the Bush Administration, she practiced law in the Washington, D.C. office of Epstein Becker & Green, P.C. where she advised clients on a variety of health policy matters. She also served in the first Bush administration in the White House Office of Presidential Personnel, and the Office of the U.S. Trade Representative.

Ms. Norwalk, a native of Dayton, OH, earned a juris doctor degree from the George Mason University School of Law, where she was a Dean’s Scholar and an editor of the George Mason Law Review. She earned a bachelor’s degree, cum laude, in economics and international relations from Wellesley College.

Lee Sacks, M.D. retired as Chief Medical Officer of Advocate Aurora Health in August 2018.   In that role, he was responsible for safety, quality, population health, insurance, claims, risk management, research, and medical education.  He previously served as Executive Vice President, Chief Medical Officer of Advocate Health Care since 1997.    From 1995 – 2018, he served as the founding CEO of Advocate Health Partners (now d/b/a Advocate Physician Partners), a clinically integrated network that includes over 5,000 physicians.  He is a nationally recognized thought leader on value-based payment arrangements.  He currently serves as a physician executive in residence for the Health Management Academy, on the board of Cedar Gate Technologies, the Board of Trustees of Rosalind Franklin University of Medicine and Science, and on the advisory boards of Prealize and Project Connect.   He is an external reviewer for New England Journal of Medicine Catalyst.

Dr. Sacks is a fellow of the Institute of Medicine, Chicago.  He practiced family medicine for thirteen years in suburban Chicago.  Dr. Sacks earned a Bachelor of Science in chemical engineering at the University of Pennsylvania.  He received his medical degree from the University of Illinois College of Medicine and completed a family practice residency at Lutheran General Hospital in Park Ridge, IL.